To our knowledge, this is the first study to assess the relationship between expression of p52, a major component of the non-canonical NF-κB pathway, and epithelial ovarian cancer prognosis, particularly high-grade serous ovarian cancer. Here, NFKB2 is linked to ovarian carcinoma.